Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays - PubMed (original) (raw)

Affiliations

PMID: 1526021

Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays

T Wong et al. Clin Chem. 1992 Sep.

Abstract

Neonatal plasma contains interferents that increase the apparent 17 alpha-hydroxyprogesterone (17-OHP) content measured by direct (no-extraction) radioimmunoassay. We fractionated extracts from neonatal plasma pools by liquid chromatography with a Sephadex LH-20 column and measured 17-OHP immunoreactivity by a direct test kit. We found immunoreactivity in the free steroid and glucuronide fraction and also in the monosulfate fraction. We analyzed these two fractions by reversed-phase high-performance liquid chromatography (HPLC) and HPLC-mass spectrometry. We collected fractions and assayed for 17-OHP immunoreactivity. The HPLC fractions containing the interfering steroid monosulfates were analyzed by ion-spray mass spectrometry and, after solvolysis, by gas chromatography-mass spectrometry. Several monosulfates were identified, including those of 17 alpha-hydroxy-pregnenolone, 16 alpha-hydroxypregnenolone, pregnenolone, and several pregnenetriols. 17 alpha-Hydroxypregnenolone sulfate was the most significant interferent. Other commercially available 17-OHP assays showed similar interference when used without an extraction step. Kit manufacturers should select antibodies and protocols to minimize cross-reaction with sulfates, especially 17 alpha-hydroxypregnenolone sulfate.

PubMed Disclaimer

Cited by

Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia?
Sarafoglou K, Gaviglio A, Wolf C, Lorentz CP, Lteif A, Kyllo J, Radloff G, Detwiler Z, Cuthbert CD, Hodges JS, Grosse SD, Greene CN, Cordovado S. Sarafoglou K, et al. J Clin Endocrinol Metab. 2024 May 3:dgae297. doi: 10.1210/clinem/dgae297. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38701341
The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.
de Hora M, Heather N, Webster D, Albert B, Hofman P. de Hora M, et al. Front Endocrinol (Lausanne). 2023 Oct 2;14:1226284. doi: 10.3389/fendo.2023.1226284. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37850096 Free PMC article. Review.
Hormone Immunoassay Interference: A 2021 Update.
Ghazal K, Brabant S, Prie D, Piketty ML. Ghazal K, et al. Ann Lab Med. 2022 Jan 1;42(1):3-23. doi: 10.3343/alm.2022.42.1.3. Ann Lab Med. 2022. PMID: 34374345 Free PMC article. Review.
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, Flück CE, Guasti L, Huebner A, Kortmann BBM, Krone N, Merke DP, Miller WL, Nordenström A, Reisch N, Sandberg DE, Stikkelbroeck NMML, Touraine P, Utari A, Wudy SA, White PC. Claahsen-van der Grinten HL, et al. Endocr Rev. 2022 Jan 12;43(1):91-159. doi: 10.1210/endrev/bnab016. Endocr Rev. 2022. PMID: 33961029 Free PMC article. Review.
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy.
Held PK, Bird IM, Heather NL. Held PK, et al. Int J Neonatal Screen. 2020 Aug 23;6(3):67. doi: 10.3390/ijns6030067. eCollection 2020 Sep. Int J Neonatal Screen. 2020. PMID: 33117906 Free PMC article. Review.

Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays - PubMed (original) (raw)